Biosense offers comprehensive solutions for Neonatal Screening centers, providing reagents and instrumentation from sample punching to result analysis software. Our portfolio includes certified instrumentation and kits for both metabolic analysis and genetic screening.
NEONATAL Biotinidase Screening Assay kit is an enzymatic test for biotinidase activity quantification.
NEONATAL TOTAL-T4 Screening ELISA is a colorimetric enzyme immunoassay for the quantitative determination of total thyroxine (TT4).
The NEONATAL IRT Screening ELISA is a colorimetric enzyme immunoassay for the quantitative determination of immunoreactive trypsinogen (IRT)
The NEONATAL PAP Screening ELISA is a colorimetric enzyme immunoassay designed for the quantitative measurement of Pancreatitis-Associated Protein (PAP).
The NEONATAL G-6-PD Screening Assay is an enzymatic test in newborns for the quantification of glucose-6-phosphate dehydrogenase (G-6-PD) activity.
The NEONATAL Total-Galactose Screening Assay is an enzymatic test used to quantify total galactose (galactose and galactose-1-phosphate)
The newborn screening kit for hemoglobinopathy evaluation is a qualitative analytical test for newborn screening for hemoglobin (Hb)-related conditions
The NEONATAL MSUD Screening Assay is a quantitative enzymatic test that assays the branched-chain amino accumulated in MSUD
NEO-C-500 is an innovative and high-performance workstation designed for the fully automated processing of ELISA test
The NEO-F-500 is an advanced and high-performance workstation designed for the fully automated processing of ELISA & FLISIA test.
The NEONATAL PKU Screening Assay is a colorimetric enzyme assay used for phenylketonuria (PKU) newborn screening
The SMA Screening solutions offered by LaCAR are CE-IVDR diagnostic assays designed for the qualitative detection of the SMN1 gene (Exon 7)
